New products
Enrolment concludes in BD’s PREVENT trial of Phasix Mesh
BD has completed patient enrolment in the PREVENT clinical trial evaluating Phasix Mesh for prevention of incisional hernias. The trial's conclusion of the enrolment phase marks a step toward potential regulatory submissions and commercialization decisions for the resorbable mesh product.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network